These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 35870109

  • 1. Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS.
    Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X.
    J Endocrinol Invest; 2022 Nov; 45(11):2131-2137. PubMed ID: 35870109
    [Abstract] [Full Text] [Related]

  • 2. Immune checkpoint inhibitor-associated new-onset hypophysitis: a retrospective analysis using the FAERS.
    Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X.
    Endocrine; 2024 Oct; 86(1):342-348. PubMed ID: 38965136
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects.
    Martella S, Lucas M, Porcu M, Perra L, Denaro N, Pretta A, Deias G, Willard-Gallo K, Parra HS, Saba L, Scartozzi M, Wekking D, Kok M, Aiello MM, Solinas C.
    Semin Oncol; 2023 Dec; 50(6):144-148. PubMed ID: 38151399
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.
    Gao S, He Z, Zhu J, Liang D, Zhao W, Yang S, Jiang W, Qiu K, Yu X, Wu J.
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1199-1205. PubMed ID: 35689298
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immune Checkpoint Inhibitor-Induced Adrenalitis and Primary Adrenal Insufficiency: Systematic Review and Optimal Management.
    Shi Y, Shen M, Zheng X, Yang T.
    Endocr Pract; 2021 Feb; 27(2):165-169. PubMed ID: 33554872
    [Abstract] [Full Text] [Related]

  • 14. Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry.
    Sun MM, Kelly SP, Mylavarapu Bs AL, Holland GN, Coleman AL, Yu F, Hsu Ms S, Lum F, Gordon LK.
    Ophthalmology; 2021 Jun; 128(6):910-919. PubMed ID: 33166553
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal adverse effects following the use of different immune checkpoint inhibitor regimens: A real-world pharmacoepidemiology study of post-marketing surveillance data.
    Chen G, Qin Y, Fan QQ, Zhao B, Mei D, Li XM.
    Cancer Med; 2020 Sep; 9(18):6576-6585. PubMed ID: 32720449
    [Abstract] [Full Text] [Related]

  • 19. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
    Jang SR, Nikita N, Banks J, Keith SW, Johnson JM, Wilson M, Lu-Yao G.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2136823. PubMed ID: 34854905
    [Abstract] [Full Text] [Related]

  • 20. Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems.
    Ma R, Wang Q, Meng D, Li K, Zhang Y.
    BMC Cancer; 2021 Jan 07; 21(1):38. PubMed ID: 33413213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.